X Facebook LinkedIn WhatsApp Press Releases (-) Any 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2017 May 1, 2017 argenx reports first quarter 2017 financial results and provides business update April 25, 2017 argenx announces results of Annual General Meeting 2017 April 23, 2017 argenx files registration statement for a proposed public offering in the United States April 12, 2017 argenx receives first preclinical milestone payment in AbbVie collaboration April 11, 2017 argenx launches Phase II study of ARGX-110 as a monotherapy in relapsed/refractory CTCL patients March 30, 2017 argenx announces first patient dosed in Phase II proof-of-concept study of ARGX-113 for the treatment of primary immune thrombocytopenia March 20, 2017 argenx announces collaboration with Broteio Pharma to develop therapeutic antibody for severe autoimmune diseases March 14, 2017 argenx announces Annual General Meeting of Shareholders 26 April 2017 March 14, 2017 argenx reports fourth quarter business update and full year 2016 financial results March 8, 2017 argenx to host conference call & webcast to report fourth quarter business update and full year 2016 financial results on March 15, 2017 March 2, 2017 argenx announces that Staten Biotech exercised its option to develop therapeutic SIMPLE AntibodyTM for dyslipidemia February 28, 2017 argenx announces intention to conduct a registered public offering in the United States Pagination First page « First Previous page ‹ Previous … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Next › Last page Last »